FinancePrivate Insurance Accounted for Nearly Half of Prescription Drug Spending in 2017
A Kaiser Family Foundation report found that 82% of total retail prescription drug spending in 2017 came from private insurers,...
CMS Issues New Guidance on PBM Up-Charging
Feds spell out how 'spread pricing' is calculated in medical loss ratios.
StrategyCivica Rx, Xellia Sign Supply Agreement to Reduce Chronic Drug Shortages
Xellia becomes Civica's first supplier partner and will produce antibiotics in short supply in U.S. hospitals.
Final Rule Requires Drug Price Disclosures in TV Ads
The final rule will require drug makers to post the list price if that price is equal to or greater...
StrategyDrug Industry Patents Go Under Senate Judiciary Committee's Microscope
The four proposed bills share a common goal: avoiding some of the thorny issues around drug pricing and instead getting...
FinanceJudge Rules 340B Cuts Unlawful, Decision Applauded by Industry Stakeholders
A federal judge reaffirmed his view that the cuts by HHS to the discount drug program are unlawful.
Amgen, Astellas to Pay $124.7M to Settle Kickback Allegations
The two companies allegedly used independent foundations to pay Medicare beneficiaries' copays for their own products, an illegal inducement under...
FinanceKroger Health President Talks 'Food as Medicine,' Prescription Drug Prices
Colleen Lindholz, president of Kroger Health, spoke about the grocery store's plans to expand further into healthcare.
StrategyConsumers Rejected Drug Plan That Mirrors Trump Administration Proposal
The CVS Caremark plan wasn't popular with customers, and CVS Health, which owns CVS Caremark, was quick to point this...
FinanceWhat to Expect at the Senate PBM Hearing
Executives from five major PBMs will take center stage on Capitol Hill Tuesday morning.
StrategyPBM Lobby Raps 'Poorly Conceived' HHS Drug Rebate Proposal
The pharmacy benefits managers-backed study says it would be 'premature' for policymakers to adopt the rule without better understanding its...
FinanceSen. Chuck Grassley Questions Insulin Pricing Efforts
In a letter released Wednesday, the Senate Finance Committee chairman said decreasing costs for patients should apply to other high-priced...